Clinical Report: Genetic Analysis of Complement Factors in Japanese Pediatric Patients
Overview
This study investigates the genetic variants associated with transplant-associated thrombotic microangiopathy (TA-TMA) in Japanese pediatric patients. No significant differences in genetic variants were found between patients with and without TA-TMA, although a novel variant in the C1RL gene was identified in one patient.
Background
Transplant-associated thrombotic microangiopathy (TA-TMA) is a serious complication following hematopoietic stem cell transplantation (HSCT), affecting a significant proportion of recipients. The condition is characterized by microangiopathic hemolytic anemia and thrombocytopenia, leading to severe organ dysfunction.
Data Highlights
No significant differences in the percentage of patients bearing genetic variants between those with and without TA-TMA were observed. A novel rare genetic variant in the C1RL gene was identified in one patient with TA-TMA.
Key Findings
No enrichment of rare variants among 40 complement- and coagulopathy-related genes was found in the cohort.
Identified several rare non-synonymous variants in TA-TMA patients, but no known pathogenic variants were detected.
The study included 44 Japanese pediatric patients, with 20 diagnosed with TA-TMA.
Clinical Implications
Further research in diverse cohorts is necessary to clarify the genetic associations.
Conclusion
This study did not find a significant association between genetic variants and TA-TMA in the Japanese pediatric population, suggesting that further research with larger cohorts is necessary to clarify these associations.
